RecruitingNCT06933836

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma


Sponsor

Barnet Dulaney Perkins Eye Centers

Enrollment

55 participants

Start Date

Mar 31, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.


Eligibility

Min Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating a diagnostic tool (DSLT) used to detect newly diagnosed type 2 diabetes in patients who have not yet been treated. The goal is to see how well this tool identifies diabetes early and accurately in a real clinical setting. **You may be eligible if...** - You have recently been diagnosed with type 2 diabetes and have not yet started medication - You are an adult presenting to a clinic for initial diabetes assessment - You are willing to undergo standard diabetes diagnostic testing **You may NOT be eligible if...** - You have already started diabetes medication (treatment-naive required) - You have type 1 diabetes or another specific form of diabetes - You have conditions that affect blood sugar tests unrelated to diabetes - You are pregnant (gestational diabetes is different) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDSLT enables newly diagnosed patients to remain well controlled and off medications

DSLT enables newly diagnosed patients to remain well controlled and off medications


Locations(1)

Barnet Dulaney Perkins Eye Centers

Mesa, Arizona, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06933836


Related Trials